Skip to main content
SpringerLink
Log in

Diagnosis and staging of children’s lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Somatostatin receptor scintigraphy (SRS) is useful in diagnosing tumours with increased expression of somatostatin receptors. Lymphoma cells are known to express somatostatin receptors; however, the application of indium-labelled analogues in children is limited. The aim of this study was to investigate whether the technetium-labelled somatostatin analogue, depreotide, may be useful in diagnosing and staging malignant lymphoma in children. Fifteen children (mean age 13.8 years) with malignant lymphoma were studied (eight with Hodgkin’s lymphoma and seven with non-Hodgkin’s lymphoma). All children were investigated for verification of staging established by other modalities. Imaging was performed 3–5 h after administration of 300–550 MBq 99mTc-depreotide. All patients underwent whole-body scan and single-photon emission tomography of the chest and/or abdomen. Images were assessed visually. In all patients, foci of increased tracer uptake were found. The neck and thorax were the most frequent lesion localisations. Abdominal lesions were found in four patients, and bone lesions in three. In two patients, diffusely increased uptake was observed throughout the skeleton (verified as representing bone marrow involvement). In 11 patients, the number of abnormal sites detected by SRS was greater than that detected by CT. Based on radionuclide examination, three children were upstaged and none were downstaged. It is concluded that 99mTc-depreotide shows increased accumulation in pathological sites in malignant lymphoma in children. SRS with 99mTc-depreotide provides a single-day imaging method with high sensitivity in lymphoma and with all the advantages of a technetium-labelled compound. Further studies are required on the specificity and the possible value of 99mTc-depreotide in the follow-up of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A, B
Fig. 2A, B
Fig. 3A, B

Similar content being viewed by others

References

  1. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716–731.

    CAS  PubMed  Google Scholar 

  2. Hiruma K, Koike T, Nakamura H, Sumida T, Maeda T, Tomioka H, Yoshida S, Fujita T. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology 1990; 71:480–485.

    CAS  PubMed  Google Scholar 

  3. Reubi JC, Waser B, van Hagen M, Lamberts SW, Krenning EP, Gebbers JO, Laissue JA. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 1992; 50:895–900.

    CAS  PubMed  Google Scholar 

  4. Goldsmith SJ, Macapinlac HM, O’Brien JP. Somatostatin receptor imaging in lymphoma. Semin Nucl Med 1995; 3:262–271.

    Google Scholar 

  5. Cerulus G, Leonard JP. A comparison of111In-octreotide and 67Ga scintigraphy in malignant lymphoma. Nucl Med Commun 1997; 18:616–622.

    Google Scholar 

  6. Virgolini I, Leimer M, Handmaker H, Lastoria S, Bischof C, Muto P, Pangerl T, Gludovacz D, Peck-Radosavljevic M, Lister-James J, Hamilton G, Kaserer K, Valent P, Dean R. Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer,99mTc-P829. Cancer Res 1998; 58:1850–1859.

    CAS  PubMed  Google Scholar 

  7. Blum J, Handmaker H, Lister-James J, Rinne N.A multicenter trial with a somatostatin analog99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117:1232–1238.

    CAS  PubMed  Google Scholar 

  8. Bares R, Galonska P, Dempke W, Handt S, Bull U, Osieka R. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography. Horm Metab Res Suppl 1993; 27:56–58.

    CAS  PubMed  Google Scholar 

  9. Schiepers C, Filmont J-E, Czernin J. PET for staging of Hodgkin’s disease and non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 1):S82–S88.

    Google Scholar 

  10. Fueger JB, Hamilton G, Raderer M, Pangerl T, Traub T, Angelberger P, Baumgartner G, Dudczak R, Virgolini I. Effect of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells. J Nucl Med 2001; 42:1856–1862.

    Google Scholar 

  11. Cholewinski W, Kowalczyk JR, Drop A, Poniatowicz-Frasunek E, Nocun A, Stefaniak B, Chrapko B, Tarkowska A. Somatostatin receptor scintigraphy in children with malignant lymphomas. Eur J Nucl Med 2001; 28:A966.

    Google Scholar 

Download references

Acknowledgements

The study was supported by the State Committee for Scientific Research (KBNP05E11321).

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Medical University of Lublin, SPSK4, Jaczewskiego 8, 20-954, Lublin, Poland

    Witold Cholewinski, Bogusław Stefaniak, Ewa Poniatowicz-Frasunek & Anna Tarkowska

  2. Department of Children’s Haematology and Oncology, Medical University of Lublin, Lublin, Poland

    Jerzy R. Kowalczyk & Jolanta Stefaniak

Authors
  1. Witold Cholewinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerzy R. Kowalczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bogusław Stefaniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jolanta Stefaniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ewa Poniatowicz-Frasunek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anna Tarkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Witold Cholewinski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cholewinski, W., Kowalczyk, J.R., Stefaniak, B. et al. Diagnosis and staging of children’s lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide. Eur J Nucl Med Mol Imaging 31, 820–824 (2004). https://doi.org/10.1007/s00259-003-1449-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1449-x

Keywords

Search

Navigation